Safety of midodrine in patients with heart failure with reduced ejection fraction: a retrospective cohort study
Conclusion: In this large-scale study, midodrine use was associated with reduced ER visits but increased risks of respiratory failure, prolonged ICU stays, higher hospitalizations, and elevated mortality in HFrEF patients. Further research is needed to clarify midodrine’s role in hemodynamic support and strengthen existing evidence.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | Cardiology | Chronic Kidney Disease | Dialysis | Drugs & Pharmacology | Emergency Medicine | Heart | Heart Failure | Intensive Care | Respiratory Medicine | Study | Urology & Nephrology